Trametinib With GSK2141795 in BRAF Wild-type Melanoma

NCT01941927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Trametinib (GSK1120212)
DRUG: GSK2141795

Sponsor

Adil Daud

Collaborators

[object Object]